Bank Of America Corp Werewolf Therapeutics, Inc. Transaction History
Bank Of America Corp
- $1.06 Trillion
- Q1 2024
A detailed history of Bank Of America Corp transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 1,881,113 shares of HOWL stock, worth $4.59 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,881,113
Previous 2,096,081
10.26%
Holding current value
$4.59 Million
Previous $8.09 Million
50.67%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding HOWL
# of Institutions
65Shares Held
26.1MCall Options Held
2.4KPut Options Held
35K-
Mpm Asset Management LLC Cambridge, MA4.28MShares$10.5 Million11.32% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA3.01MShares$7.34 Million0.96% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3MShares$7.32 Million0.04% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.39MShares$5.83 Million2.53% of portfolio
-
Janus Henderson Group PLC London, X01.69MShares$4.12 Million0.01% of portfolio
About Werewolf Therapeutics, Inc.
- Ticker HOWL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,529,400
- Market Cap $72.1M
- Description
- Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...